Advertisement
Advertisement
U.S. Markets open in 6 hrs 57 mins
Advertisement
Advertisement
Advertisement
Advertisement

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
160.73-1.27 (-0.78%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close162.00
Open162.53
Bid125.00 x 900
Ask168.95 x 800
Day's Range160.30 - 162.75
52 Week Range82.25 - 219.75
Volume102,156
Avg. Volume200,861
Market Cap2.676B
Beta (5Y Monthly)1.06
PE Ratio (TTM)66.89
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJul 02, 2010
1y Target EstN/A
  • Zacks

    Ligand's (LGND) Drug-Developing Technologies Holds Potential

    Ligand's (LGND) Captisol technology is a key driver for its topline. The company plans to spin off another potential technology platform, OmniAb, into a separate company.

  • Benzinga

    Ligand Pharmaceuticals Insider Sold Over $480K In Company Stock

    John L Higgins, Insider at Ligand Pharmaceuticals (NASDAQ:LGND), made a large insider sell on November 12, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Higgins sold 3,000 shares of Ligand Pharmaceuticals at a price of $160.50. The total transaction amounted to $481,500. Following the transaction, Higgins still owns 335,095 shares of the company, worth $53,065,644. Ligand Pharmaceuticals shares are trading dow

  • Investor's Business Daily

    Ligand Pharmaceuticals Sees RS Rating Rise To 92

    A Relative Strength Rating upgrade for Ligand Pharmaceuticals shows improving technical performance.

Advertisement
Advertisement